IHC analysis of additional iBRAF* prostate tumors (n = 17) mirrored these Western blot results, showing absence of AKT activation and readily detectable p-S6 immunoreactivity (Figure 5C). This evidence concerns the gene AKT1 and prostate neoplasm.